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Backgrounds: Soluble LOX-1 levels in the peripheral circulation have been reported as a useful biomarker for diagnosis of acute myocardial 
infarction. However, the association of soluble LOX-1 with in vivo plaque vulnerability has not been rigorously examined. Aim: We investigated the 
levels of soluble LOX-1 in systemic and coronary circulation. 
Methods: This study included 28 patients with acute coronary syndrome (ACS) and 51 patients with stable effort angina pectoris (EAP) who 
underwent percutaneous coronary intervention (PCI). We measured levels of soluble LOX-1 in paired blood samples from aorta (Ao) and coronary 
sinus (CS) at the same time just prior to PCI by a newly established ELISA. 
Results: Soluble LOX-1 levels in Ao and CS were significantly higher in ACS than in EAP (P<0.0001, each). We found the positive correlation between 
Ao and CS LOX-1 values in ACS (R=0.676, P<0.0001), but not in EAP, suggesting that elevated LOX-1 was derived from coronary circulation. The LOX-
1 values increased earlier after the onset compared to other markers for ACS such as CK-MB and troponin I. Correlations between LOX-1 and CK-MB, 
troponin I or CRP were not observed in ACS. 
Conclusions: This study showed that soluble LOX-1 levels in coronary circulation were elevated in ACS, suggesting that soluble LOX-1 is a specific 
biomarker of vulnerable plaque in ACS.
